Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.numecd.2020.04.013 http://scihub22266oqcxt.onion/10.1016/j.numecd.2020.04.013 32456948!7165120!32456948     free     free     free Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Nutr+Metab+Cardiovasc+Dis 2020 ; 30 (7): 1061-1067 Nephropedia Template TP {{tp|p=32456948|t=2020. Cardiovascular disease potentially contributes to the progression and poor prognosis of COVID-19 |pdf=|usr=}}{{32456948}} gab.com Text Cardiovascular disease potentially contributes to the progression and poor prognosis of COVID-19 JO: Nutr Metab Cardiovasc Dis http://www.kidney.de/pget.php?&tw=1&pmid=32456948 #FOAvip BACKGROUND AND AIM: A novel coronavirus severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) caused pneumonia, Coronavirus Disease 2019 (COVID-19), broke out in Wuhan, China in December 2019, and spread all over the world. Patients with COVID-19 showed huge differences in the hospital stay, progression, and prognosis. As reported, the comorbidities may play an important role in COVID-19. Here, we aim to address the role of cardiovascular disease (CVD) in the progression and prognosis of COVID-19. METHODS AND RESULTS: Eighty-three confirmed COVID-19 patients were divided into CVD (n = 42) and non-CVD (n = 41) group according to their medical history. Medical records including demographic data, medical history, clinical characteristics, laboratory examinations, chest computed tomography (CT), and treatment measures were collected, analyzed, and compared between the two groups. COVID-19 patients with CVD showed (1) more severe pathological changes in the lungs, (2) elevated injury-related enzymes including alpha-hydroxybutyrate dehydrogenase (HDBH), lactic dehydrogenase (LDH), gamma-glutamyltransferase (GGT), creatine kinase (CK), and alanine aminotransferase (ALT), (3) significantly increased uncontrolled inflammation related markers, such as c-reactive protein (CRP), interleukin (IL)-6, serum ferritin, erythrocyte sedimentation rate (ESR), and serum amyloid A (SAA), (4) serious hypercoagulable status reflected by increased D-dimer and serum fibrinogen (FIB), and (5) higher mortality, compared to COVID-19 patients without CVD. CONCLUSIONS: Our data indicated that CVD is a strong risk factor for rapid progression and bad prognosis of COVID-19. More intensive medical care should be applied to patients with CVD to prevent rapid deterioration of the disease. Twit Text FOAVip Cardiovascular disease potentially contributes to the progression and poor prognosis of COVID-19 ????Nutr Metab Cardiovasc Dis http://www.kidney.de/pget.php?&tw=1&pmid=32456948 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32456948 #FOAvip English Wikipedia <ref>{{Cite pmid|32456948}}</ref> Cardiovascular disease potentially contributes to the progression and poor prognosis of COVID-19 #MMPMID32456948 Li M; Dong Y; Wang H; Guo W; Zhou H; Zhang Z; Tian C; Du K; Zhu R; Wang L; Zhao L; Fan H; Luo S; Hu D Nutr Metab Cardiovasc Dis 2020[Jun]; 30 (7): 1061-1067 PMID32456948show ga BACKGROUND AND AIM: A novel coronavirus severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) caused pneumonia, Coronavirus Disease 2019 (COVID-19), broke out in Wuhan, China in December 2019, and spread all over the world. Patients with COVID-19 showed huge differences in the hospital stay, progression, and prognosis. As reported, the comorbidities may play an important role in COVID-19. Here, we aim to address the role of cardiovascular disease (CVD) in the progression and prognosis of COVID-19. METHODS AND RESULTS: Eighty-three confirmed COVID-19 patients were divided into CVD (n = 42) and non-CVD (n = 41) group according to their medical history. Medical records including demographic data, medical history, clinical characteristics, laboratory examinations, chest computed tomography (CT), and treatment measures were collected, analyzed, and compared between the two groups. COVID-19 patients with CVD showed (1) more severe pathological changes in the lungs, (2) elevated injury-related enzymes including alpha-hydroxybutyrate dehydrogenase (HDBH), lactic dehydrogenase (LDH), gamma-glutamyltransferase (GGT), creatine kinase (CK), and alanine aminotransferase (ALT), (3) significantly increased uncontrolled inflammation related markers, such as c-reactive protein (CRP), interleukin (IL)-6, serum ferritin, erythrocyte sedimentation rate (ESR), and serum amyloid A (SAA), (4) serious hypercoagulable status reflected by increased D-dimer and serum fibrinogen (FIB), and (5) higher mortality, compared to COVID-19 patients without CVD. CONCLUSIONS: Our data indicated that CVD is a strong risk factor for rapid progression and bad prognosis of COVID-19. More intensive medical care should be applied to patients with CVD to prevent rapid deterioration of the disease. |*Betacoronavirus[MESH] |*Cause of Death[MESH] |*Disease Progression[MESH] |Adult[MESH] |Aged[MESH] |Biomarkers/blood[MESH] |Blood Chemical Analysis[MESH] |C-Reactive Protein/metabolism[MESH] |COVID-19[MESH] |Cardiovascular Diseases/diagnosis/*epidemiology/therapy[MESH] |China/epidemiology[MESH] |Cohort Studies[MESH] |Comorbidity[MESH] |Coronavirus Infections/diagnosis/*epidemiology/therapy[MESH] |Databases, Factual[MESH] |Disease Outbreaks/*statistics & numerical data[MESH] |Female[MESH] |Humans[MESH] |Male[MESH] |Middle Aged[MESH] |Pandemics[MESH] |Pneumonia, Viral/diagnosis/*epidemiology/therapy[MESH] |Reference Values[MESH] |Retrospective Studies[MESH] |SARS-CoV-2[MESH] |Survival Analysis[MESH]Cardiovascular disease potentially contributes to the progression and (epmc).pdf DeepDyve Pubget Overpricing